Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 9:12:827-832.
doi: 10.2147/JBM.S328547. eCollection 2021.

Correlation of Transferrin Saturation and Serum Ferritin with Bone Mass Density in Adult Transfusion Dependent Beta-Thalassemia Patients

Affiliations

Correlation of Transferrin Saturation and Serum Ferritin with Bone Mass Density in Adult Transfusion Dependent Beta-Thalassemia Patients

Tubagus Djumhana Atmakusuma et al. J Blood Med. .

Abstract

Background: The use of regular blood transfusions and iron chelation therapy to treat thalassemia has improved survival and increased the incidence of osteoporosis. Moreover, iron toxicity is one of the contributing factors that reduce bone mass density in adult transfusion-dependent beta-thalassemia patients. Therefore, this study aims to determine the proportion of low bone mass density in adult thalassemia patients and transferrin saturation, as well as serum ferritin, which correlates to the skeletal condition.

Methods: This is a cross-sectional study conducted in Thalassemia and Hematology Medical Oncology Clinics of Cipto Mangunkusumo Hospital in March 2016. The anthropometric data and hemoglobin levels were obtained before transfusion. Subsequently, the average ferritin levels, bone mineral density, and radiographic results were obtained.

Results: The percentage of adult thalassemia major and intermedia patients with low bone mass density was 68%. Also, there was a weak inverse correlation between bone mass density and transferrin saturation (r = -0.329, p = 0.01), while no correlation was shown between bone mass density and ferritin (r = -0.088, p = 0.504). The transferrin saturation cutoff point value used to distinguish the incidence of low and normal bone density in patients with transfusion-dependent beta-thalassemia was 89.5%. In addition, there was weak correlation between Singh index and bone mass density (r = 0.273, p = 0.038).

Conclusion: Among the transfusion-dependent beta-thalassemia patients, 68% had low bone mass density, which inversely correlated to transferrin saturation. Furthermore, the cutoff value of transferrin saturation to differentiate the incidence of low and normal bone density in thalassemia major compared to thalassemia intermedia was 89.5%. Singh Index correlates weakly with bone mass density and might be used to detect low bone mass density in remote healthcare facilities.

Keywords: bone mass density; ferritin; thalassemia; transferrin; transfusion dependent beta.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Transferrin saturation values receiver operating characteristic (ROC) curve for prediction of future occurrence of low bone density in adult thalassemia patients.
Figure 2
Figure 2
Cutoff point of transferrin saturation in distinguishing incidence of low bone density in adult patients with thalassemia.

References

    1. Rachmilewtiz E, Giardina P. How I treat thalassemia. Blood. 2011;118:3479–3488. doi:10.1182/blood-2010-08-300335 - DOI - PubMed
    1. Thein SL. Pathophysiology of β-thalassemia-A guide to molecular therapies. Am Soc Hematol Educ Prog. 2005;2005:31–37. doi:10.1182/asheducation-2005.1.31 - DOI - PubMed
    1. Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, et al. Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab. 2003;88:3966–3972. doi:10.1210/jc.2002-021548 - DOI - PubMed
    1. Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circ. 2011;124:2253–2263. doi:10.1161/CIRCULATIONAHA.111.050773 - DOI - PubMed
    1. Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann NY Acad Sci. 2010;1202:1–9. doi:10.1111/j.1749-6632.2010.05544.x - DOI - PubMed

LinkOut - more resources